Navigation Links
Clinical Innovation Outsourcing Awards Deadline Extension: Friday 2nd March
Date:2/29/2012

LONDON, February 29, 2012 /PRNewswire/ --

Due to the popular demand, Pharma IQ has extended the nomination deadline for the Clinical Innovation Outsourcing Award for Dynamic Leadership in the Pharma and Biotech Industry.

The Clinical Outsourcing Innovation Awards 2012 has been designed to highlight key achievements made by individual companies within the R&D industry that have improved efficiencies and furthered the definition of innovation. The award will be reviewed for Dynamic Leadership in the Pharma and Biotech Industry.

The Award nominees will be judged by the following criteria:

  • Impact to company, business or end user
  • Novelty, pursuit of entrepreneurship and industry best practice
  • Technical excellence, content, validity and applicability
  • Excellence in efficiency or improvements (cost cutting, improvement docs, service levels, patient safety, reduced risk, streamlined processes, etc)

Online voting will open this March allowing the community at large to vote. Additionally, there will be onsite voting at the Global Clinical Outsourcing Forum.

The delegation will have the opportunity to review the nominees and cast their vote. The awards presentation will be at the end of the first day of the Global Clinical Outsourcing Forum.

To enter the orders, one has to complete the nomination form and send it, along with supplementary information to support the nomination to Nicola Ambler at nicola.ambler@iqpc.co.uk. The nomination form can be obtained from the website: http://www.globalclinicaloutsourcing.com/Event.aspx?id=675738

The Clinical Innovation Outsourcing Award was designed as a part of the Global Clinical Outsourcing Forum, taking place 24-25 April, 2012 in Amsterdam. The event brings together 20 leading industry experts and is completely presentation free providing an interactive, discussion based forum for clinical outsourcing experts.

For more information about the event, please visit http://www.globalclinicaloutsourcing.com/NEWS, email: enquire@iqpc.co.uk or call +44(0)20-7036-1300

Media contact : Joanna Checinska, +44(0)20-7368-9421, joanna.checinska@iqpc.co.uk  - Please contact for more information or images.

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (Joanna.checinska@iqpc.co.uk)


'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Crothall Healthcare Introduces Clinical Equipment Solutions Division
2. OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
3. Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicines 28th Annual Meeting
4. New Data Suggest Minimally Invasive, Video-Assisted Thorascopic Wedge Resections for Lung Cancer Provide Clinical and Economic Advantages to Patients, Hospitals and Payors
5. Preclinical Study Examines Use of nContacts Technology in Enabling a Percutaneous Device Approach to Epicardial Ablation
6. NW Bio Reaches 30 Clinical Trial Sites Ahead of End-of-Q1 Projection
7. Elsevier Integrates its Clinical Decision Support Solutions Into PatientKeeper CPOE
8. Acuo Technologies Updates the Universal Clinical Platform
9. Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™
10. Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update
11. Inclinix, Inc. and JSW Life Sciences Announce Formal Strategic Partnership for European Clinical Trial Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017 Cardiology devices segment is anticipated to ... The Cardiology Devices segment is likely to create absolute ... in 2018 over 2017. By the end of 2027, Cardiology ... to US$ 700 Mn, expanding at a CAGR of 18.4% ... Asia Pacific reprocessed medical devices market ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):